In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis

Journal of Medical Microbiology

Volumn 59, Issue 5, 2010, Pages 567-572

  Ge, Fa ^a   Zeng, Fanli ^b   Liu, Siguo ^c   Guo, Na ^a   Ye, Haiqing ^a   Song, Yu ^a   Fan, Junwen ^d   Wu, Xiuping ^a   Wang, Xuelin ^a   Deng, Xuming ^a   Jin, Qi ^e   Yu, Lu ^a  

^a JILIN UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c Harbin Veterinary Research Institute   (China)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^e INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; OLEANOLIC ACID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; FRACTIONATION; IC 50; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; VERO CELL; DRUG EFFECT; DRUG POTENTIATION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG SYNERGISM; ETHAMBUTOL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OLEANOLIC ACID; RIFAMPIN; TUBERCULOSIS;

EID: 77951644512     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.014837-0     Document Type: Article

References (23)

1. Bamuamba, K., Gammon, D. W., Meyers, P., Dijoux-Franca, M. G. & Scott, G. (2008). Anti-mycobacterial activity of five plant species used as traditional medicines in the Western Cape Province (South Africa). J Ethnopharmacol 117, 385-390.
2. Banno, N., Akihisa, T., Tokuda, H., Yasukawa, K., Higashihara, H., Ukiya, M., Watanabe, K., Kimura, Y., Hasegawa, J. & Nishino, H. (2004). Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects. Biosci Biotechnol Biochem 68, 85-90.
3. Bloom, B. R. & Murray, C. J. (1992). Tuberculosis: commentary on a reemergent killer. Science 257, 1055-1064.
4. Caldwell, C. G., Franzblau, S. G., Suarez, E. & Timmermann, B. N. (2000). Oleanane triterpenoids from Junellia tridens. J Nat Prod 63, 1611-1614.
5. De Logu, A., Onnis, V., Saddi, B., Congiu, C., Schivo, M. L. & Cocco, M. T. (2002). Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis. J Antimicrob Chemother 49, 275-282.
6. De Logu, A., Saddi, M., Onnis, V., Sanna, C., Congiu, C., Borgna, R. & Cocco, M. T. (2005). In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium. Int J Antimicrob Agents 26, 28-32.
7. Deng, J. Z., Starck, S. R. & Hecht, S. M. (2000). Pentacyclic triterpenoids from Freziera sp. that inhibit DNA polymerase. Bioorg Med Chem 8, 247-250.
8. Dye, C. (2009). Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol 7, 81-87.
9. Gu, J. Q., Wang, Y., Franzblau, S. G., Montenegro, G. & Timmermann, B. N. (2004). Constituents of Quinchamalium majus with potential antitubercular activity. Z Naturforsch C 59, 797-802.
10. Kent, R. J., Bakhtiar, M. & Shanson, D. C. (1992). The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulare. J Antimicrob Chemother 30, 643-650.
11. Koenig, R. (2008). Drug-resistant tuberculosis: in South Africa, XDR TB and HIV prove a deadly combination. Science 319, 894-897.
12. Kremer, L. S. & Besra, G. S. (2002). Current status and future development of antitubercular chemotherapy. Expert Opin Investig Drugs 11, 1033-1049.
13. Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 49, 57-68.
14. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
15. Newton, S. M., Lau, C. & Wright, C. W. (2000). A review of antimycobacterial natural products. Phytother Res 14, 303-322.
16. Ovesna, Z., Vachalkova, A., Horvathova, K. & Tothova, D. (2004). Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma 51, 327-333.
17. Somova, L. O., Nadar, A., Rammanan, P. & Shode, F. O. (2003). Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 10, 115-121.
18. Stratton, C. W. & Cooksey, R. C. (1991). Susceptibility tests: special tests. In The Manual of Clinical Microbiology, 5th edn, pp. 1153-1165.
19. Edited by A. Balows, W. J. Hausler, Jr, K. L. Hermann, H. D. Isenberg & H. J. Shadomy. Washington, DC: American Society for Microbiology.
20. Tanachatchairatana, T., Bremner, J. B., Chokchaisiri, R. & Suksamrarn, A. (2008). Antimycobacterial activity of cinnamatebased esters of the triterpenes betulinic, oleanolic and ursolic acids. Chem Pharm Bull (Tokyo) 56, 194-198.
21. WHO (2000). Anti-Tuberculosis Drug Resistance in the World. Report No. 2: Prevalence and Trends, WHO/CDS/TB/2000.278. Geneva: World Health Organization.
22. WHO (2009). Global Tuberculosis Control: Epidemiology, Strategy, Financing, WHO/HTM/TB/2009.411. Geneva: World Health Organization.
23. Yoon, Y. H., Jung, K. H., Sadun, A. A., Shin, H. C. & Koh, J. Y. (2000). Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc. Toxicol Appl Pharmacol 162, 107-114.